Acurx Pharmaceuticals, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACXP, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
5
Funds holding
$31477
Total value held
Buying
2 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $24115 | 6500 | — | Held |
| 2 | Wells Fargo & Company/Mn | $5727 | 2300 | — | NEW BUY |
| 3 | Barclays Plc | $1410 | 380 | — | NEW BUY |
| 4 | Blackrock, Inc. | $223 | 60 | — | Held |
| 5 | Citigroup Inc | $2 | 1 | -452 | -99.78% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.